Hepatitis B Immune Globulin vs Nivolumab

## Hepatitis B Immune Globulin vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Hepatitis B Immune Globulin** and **Nivolumab**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Hepatitis B Immune Globulin — N/A; Nivolumab — 27 days.

## Chemical Properties

**Type**: Hepatitis B Immune Globulin — Unknown; Nivolumab — Antibody.